Все публикации

0:30:09

The Story of Microdose Music | Music as Medicine | Microdose Music

0:20:51

Rexis Biotech: Improving Functional Ingredients With Innovative Technology

0:30:55

Ethical Implications - Australian Rescheduling Summit

0:14:07

Healing REIT: Investing in Real Estate to Support Growing Demand for Psychedelic Therapy

0:13:53

Discover the Innovative Approach to Mental Health Treatment with Cybin CEO - Exclusive Interview

0:10:56

Interview with Enthea CEO & Co-Founder

0:01:13

Plant Medicine Week: Recap

0:26:09

Interview with the founder and CEO of Quantified Citizen about the #psychedelic medicine industry

0:35:29

Interview with Roth Capital Analyst about the #psychedelic medicine industry

0:24:57

Alfred Wong, Origin Therapeutics — Plant Medicine Week

0:20:46

Abraham Dreazen, IMIO Life — Plant Medicine Week

0:30:41

Klee Irwin, Irwin Naturals — Plant Medicine Week 2022

0:26:59

Psychedelic Insiders #22 - Doug Drysdale, CEO of Cybin

0:01:00

Cathie Wood & ARK Increase Support Nearly 4x for Psychedelics | Microdose Psychedelic Insights

0:05:36

'Why does LSD Last so Long?' Q&A w/ Dr. Tal Hasson, CTO at Nextage Therapeutics | The LSD Conference

0:14:07

Psychotherapy With LSD? 🧠 Current LSD Mental Health Research | The LSD Conference

0:03:25

Microdosing LSD — At Home vs In-Lab — Justin Hanka, Co-Founder & Director, MindBio

0:00:45

Consolidation in Psychedelics Industry in 2022? Cody Shandraw, Managing Partner @ Ambria Capital

0:01:00

Big Pharma and Psychedelics in 2022? Doug Drysdale, CEO at Cybin Inc.

0:01:00

What Will 2022 Look Like for Psychedelics? Tesla La Touche, CEO @ Zymonetics (Part 1/3)

0:01:19

Ketamine (Therapy) to the Rescue! — Klee Irwin, CEO Irwin Naturals

0:03:12

Fantastic Functional Fungi 🧠 🍄 — Spore Life Sciences Story

0:01:00

VR Therapy Teaches Mindfulness WITHOUT Training

0:01:01

Veterans Want Access to Psychedelics